Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when VERU files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsVeru reports Q2 fiscal 2026 earnings results via press release
Filed May 13, 2026 · Period ending May 13, 2026 · ~1 min read
Key Changes
-
medium
Veru announced financial results for the quarter and six months ended March 31, 2026. Actual figures are in the attached press release (Exhibit 99.1), not in the 8-K body itself.
Item 2.02 verify on EDGAR →
Summary
Veru Inc. filed an 8-K to announce its second quarter and six-month fiscal 2026 financial results via press release on May 13, 2026. This is a routine earnings disclosure filing. The 8-K itself does not contain the actual revenue, earnings, or other financial metrics—those details are in the attached press release (Exhibit 99.1).
Retail investors should review the press release for the company's operating performance, cash position, and any forward guidance. Watch for management commentary on product pipeline progress or commercialization milestones in the full earnings materials, as Veru's valuation hinges on clinical and regulatory developments.
Section-by-Section Diff
Event · Item 9.01 — Financial Statements and Exhibits
Veru Inc. filed an 8-K attaching a press release issued May 13, 2026; no material business event disclosed in the filing body.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Press Release of Veru Inc., issued May 13, 2026.
The 8-K references an attached press release dated May 13, 2026 as Exhibit 99.1. The filing body itself contains no substantive disclosure about the press release content or the underlying corporate event being announced.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 5, 2026 · How we verify